244 related articles for article (PubMed ID: 12533163)
1. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus.
Srivastava M; Rencic A; Diglio G; Santana H; Bonitz P; Watson R; Ha E; Anhalt GJ; Provost TT; Nousari CH
Arch Dermatol; 2003 Jan; 139(1):45-9. PubMed ID: 12533163
[TBL] [Abstract][Full Text] [Related]
2. Ro/SSA antigen in human epidermis.
Jones SK; Coulter S; Harmon C; Norris DA; Rosandich M; Lee LA
Br J Dermatol; 1988 Mar; 118(3):363-7. PubMed ID: 3258526
[TBL] [Abstract][Full Text] [Related]
3. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice.
Lee LA; Gaither KK; Coulter SN; Norris DA; Harley JB
J Clin Invest; 1989 May; 83(5):1556-62. PubMed ID: 2651477
[TBL] [Abstract][Full Text] [Related]
4. Statin-induced Ro/SSa-positive subacute cutaneous lupus erythematosus.
Suchak R; Benson K; Swale V
Clin Exp Dermatol; 2007 Sep; 32(5):589-91. PubMed ID: 17692061
[No Abstract] [Full Text] [Related]
5. Autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosus.
Verdelli A; Coi A; Marzano AV; Antiga E; Cozzani E; Quaglino P; La Placa M; Benucci M; De Simone C; Papini M; Parodi A; Bianchi F; Caproni M
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):742-752. PubMed ID: 29924416
[TBL] [Abstract][Full Text] [Related]
6. The autoantibody response to Ro/SSA in cutaneous lupus erythematosus.
Lee LA; Roberts CM; Frank MB; McCubbin VR; Reichlin M
Arch Dermatol; 1994 Oct; 130(10):1262-8. PubMed ID: 7944507
[TBL] [Abstract][Full Text] [Related]
7. Detection of Ro/SS-A antibodies in lupus erythematosus: what does it mean for the dermatologist?
Böckle BC; Stanarevic G; Sepp NT
J Am Acad Dermatol; 2013 Mar; 68(3):385-94. PubMed ID: 23069705
[TBL] [Abstract][Full Text] [Related]
8. Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.
López-Longo FJ; Monteagudo I; González CM; Grau R; Carreño L
Lupus; 1997; 6(1):32-9. PubMed ID: 9116716
[TBL] [Abstract][Full Text] [Related]
9. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-Ro(SSA) antibodies by gel double diffusion and a 'sandwich' ELISA in systemic and subacute cutaneous lupus erythematosus and Sjögren's syndrome.
Provost TT; Levin LS; Watson RM; Mayo M; Ratrie H
J Autoimmun; 1991 Feb; 4(1):87-96. PubMed ID: 1903247
[TBL] [Abstract][Full Text] [Related]
11. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
Franceschini F; Calzavara-Pinton P; Valsecchi L; Quinzanini M; Zane C; Facchetti F; Airò P; Cattaneo R
Adv Exp Med Biol; 1999; 455():167-71. PubMed ID: 10599339
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of double immunodiffusion, ELISA, western blot and CAPE blot for the detection of anti-SSA antibody: study of anti-SSA prevalence in systemic lupus erythematosus.
Chretien P; Soulie E; Johanet C; Abuaf N
J Autoimmun; 1994 Jun; 7(3):379-88. PubMed ID: 7916909
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.
Sontheimer RD; Henderson CL; Grau RH
Arch Dermatol Res; 2009 Jan; 301(1):65-70. PubMed ID: 18797894
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced lupus: an update on its dermatologic aspects.
Marzano AV; Vezzoli P; Crosti C
Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies of neonatal lupus erythematosus.
Lee LA; Frank MB; McCubbin VR; Reichlin M
J Invest Dermatol; 1994 Jun; 102(6):963-6. PubMed ID: 8006461
[TBL] [Abstract][Full Text] [Related]
16. [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
Gantzer A; Regnier S; Cosnes A; Ortonne N; Wolkenstein P; Bagot M; Duong TA
Ann Dermatol Venereol; 2011 May; 138(5):409-17. PubMed ID: 21570567
[TBL] [Abstract][Full Text] [Related]
17. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
Popovic K; Nyberg F; Wahren-Herlenius M; Nyberg F
Arthritis Rheum; 2007 Jan; 56(1):255-64. PubMed ID: 17195229
[TBL] [Abstract][Full Text] [Related]
18. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions.
Adachi A; Nagai H; Horikawa T
Dermatology; 2007; 214(1):85-8. PubMed ID: 17191054
[TBL] [Abstract][Full Text] [Related]
19. Clinical follow-up of 102 anti-Ro/SSA-positive patients with dermatological manifestations.
Popovic K; Wahren-Herlenius M; Nyberg F
Acta Derm Venereol; 2008; 88(4):370-5. PubMed ID: 18709308
[TBL] [Abstract][Full Text] [Related]
20. ANA negative systemic lupus erythematosus sera revisited serologically.
Reichlin M
Lupus; 2000; 9(2):116-9. PubMed ID: 10787008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
